The Tip Desk

SOPHIA GENETICS SA holding history

As of Nov. 6, 2026 (UTC)

← AKRE CAPITAL MANAGEMENT LLC portfolio · ORDINARY SHARES · CUSIP H82027105 · SH

Quarter-end history; absent and withheld figures are not zero
March 31, 20252,237,504$7,428,5130.07%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewMay 13, 2025
June 30, 20253,719,140$11,529,3340.11%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewAug. 14, 2025
Sept. 30, 20253,719,140$17,703,1060.18%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewNov. 13, 2025
Dec. 31, 20253,719,140$17,368,3840.19%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewFeb. 13, 2026
March 31, 20263,719,140$18,409,7430.30%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewMay 14, 2026
June 30, 20263,719,140$21,459,4380.42%Withheld — Comparison unavailable: Comparable change withheld pending corporate-action reviewAug. 14, 2026

6 rows · Sort by column; scroll horizontally for more.

Schedule 13G disclosures

SOPHiA GENETICS SA · SC 13G · Event June 20, 2025 · Filed June 27, 2025
SEC original disclosureAccepted June 27, 2025 at 21:47 UTCLinked to a portfolio holding: No source restrictions recordedSOPHIA GENETICS SA history
Separate reporting persons; overlapping shares are never summed. Percent of class is not portfolio weight.
Reporting personReported shares% of security classGroup box
AKRE CAPITAL MANAGEMENT, LLC3,719,140.005.6%b
Braddock Partners Offshore, LP3,719,140.005.6%b
Braddock Capital Offshore, LLC3,719,140.005.6%b
About reported holdings

13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.